18F-FDG UPTAKE PREDICTS THE PRESENCE OF EGFR MUTATIONS IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Na, I. I. [1 ]
Byun, B. H. [1 ]
Kim, K. M. [2 ]
Cheon, G. J.
Choe, D. H. [3 ]
Koh, J. S. [4 ]
Ryoo, B. [1 ]
Yang, S. H. [1 ]
Kim, C. H. [1 ]
Lee, J. C. [1 ]
机构：
[1] Korea Canc Ctr Hosp, Korea Inst Radiol & Med Sci, Dept Internal Med, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Korea Inst Radiol & Med Sci, Dept Nucl Med, Seoul, South Korea
[3] Korea Canc Ctr Hosp, Korea Inst Radiol & Med Sci, Dept Radiol, Seoul, South Korea
[4] Korea Canc Ctr Hosp, Korea Inst Radiol & Med Sci, Dept Pathol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] EGFR mutations in non-small-cell lung cancer reply
    Mitsudomi, Tetsuya
    Yatabe, Yasushi
    LANCET ONCOLOGY, 2010, 11 (05): : 413 - 413
  • [32] Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer FDG Uptake and Risk Stratification
    Moon, Seung Hwan
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Choi, Joon Young
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (02) : E60 - E67
  • [33] Gut 18F-FDG Uptake in Lung Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) : 18N - 18N
  • [34] Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer
    Shi, Aiqi
    Wang, Jianling
    Wang, Yuzhu
    Guo, Guorong
    Fan, Chouchou
    Liu, Jiangyan
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (04) : 393 - 400
  • [35] 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer
    Zhang, Fengxian
    Wu, Xiaodong
    Zhu, Junjie
    Huang, Yan
    Song, Xiao
    Jiang, Lei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (10) : 3250 - 3259
  • [36] Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer
    Aiqi Shi
    Jianling Wang
    Yuzhu Wang
    Guorong Guo
    Chouchou Fan
    Jiangyan Liu
    Annals of Nuclear Medicine, 2022, 36 : 393 - 400
  • [37] Prognostic Value of Metabolic Tumor Burden from 18F-FDG PET in Surgical Patients with Non-small-cell Lung Cancer
    Zhang, Hao
    Wroblewski, Kristen
    Liao, Shengri
    Kampalath, Rony
    Penney, Bill C.
    Zhang, Yi
    Pu, Yonglin
    ACADEMIC RADIOLOGY, 2013, 20 (01) : 32 - 40
  • [38] 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer
    Fengxian Zhang
    Xiaodong Wu
    Junjie Zhu
    Yan Huang
    Xiao Song
    Lei Jiang
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3250 - 3259
  • [39] Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
    Kim, Chang Gon
    Hwang, Sang Hyun
    Kim, Kyung Hwan
    Yoon, Hong In
    Shim, Hyo Sup
    Lee, Ji Hyun
    Han, Yejeong
    Ahn, Beung-Chul
    Hong, Min Hee
    Kim, Hye Ryun
    Cho, Byoung Chul
    Cho, Arthur
    Lim, Sun Min
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [40] 18F-FDG uptake on positron emission tomography in gefitinib-treated non-small cell lung cancer patients
    Na, I.
    Byun, B.
    Kang, H.
    Cheon, G.
    Kim, C.
    Koh, J.
    Choe, D.
    Ryoo, B.
    Lim, S.
    Lee, J.
    Yang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345